To generate a statistical snapshot of physicians' perspectives and treatment practices regarding use of onabotulinumtoxinA (onabotA) for treating chronic migraine during pregnancy.
No takes yet. Share an insight, caveat, or question.
Nofar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: